GnRH receptor and peritoneal plasmin activity

Gynecological Endocrinology

Volumn 26, Issue 9, 2010, Pages 669-672

  Suzuki, Noriko ^a   Yamamoto, Akio ^a   Furui, Tatsuro ^a   Imai, Atsushi ^b  

^a GIFU UNIVERSITY   (Japan)

^b Matsunami General Hospital   (Japan)

Author keywords

Gonadotropin releasing hormone analogue; peritoneal cell; plasminogen activator; plasminogen activator inhibitor

Indexed keywords

BUSERELIN; DNA; GOSERELIN; LEUPRORELIN; MESSENGER RNA; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR;

ANTIGEN EXPRESSION; ARTICLE; CELL CULTURE; CELL LYSATE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE AMPLIFICATION; HUMAN; HUMAN CELL; INFERTILITY; PELVIS PAIN SYNDROME; PERITONEUM; PERITONEUM CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMALL INTESTINE OBSTRUCTION;

BUSERELIN; CELLS, CULTURED; ENZYME ACTIVATION; FIBRINOLYSIN; GENE EXPRESSION; GONADOTROPIN-RELEASING HORMONE; GOSERELIN; HUMANS; LEUPROLIDE; PERITONEUM; PLASMINOGEN ACTIVATOR INHIBITOR 1; RECEPTORS, LHRH; TISSUE PLASMINOGEN ACTIVATOR;

EID: 77955784234     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513591003686338     Document Type: Article

References (12)

1. Aarons CB, Cohen PA, Gower A, Reed KL, Leeman SE, Stucchi, AF, Becker JM. Statins (HMG-CoA reductase inhibitors) decrease postoperative adhesions by increasing peritoneal fibrinolytic activity. Ann Surg 2007;245:176-184.
2. Coddington C, Grow D, Ahmed M, Toner J, Cook E, Diamond M. Gonadotropin-releasing hormone agonist pretreatment did not decrease postoperative adhesion formation after abdominal myomectomy in a randomized control trial. Fertil Steril 2009;91:1909-1913.
3. Ray N, Denton W, Thamer M, Henderson S, Perry S. Abdominal adhesiolysis: inpatient care and expenditures in the United States in 1994. J Am Coll Surg 1998;186:1-9.
4. Wright J, Sharpe-Timms K. Gonadotropin-releasing hormone agonist therapy reduces postoperative adhesion formation and reformation after adhesiolysis in rat models for adhesion formation and endometriosis. Fertil Steril 1995;63:1094-1100.
5. Sharpe-Timms K, Zimmer R, Jolliff W, Wright J, Nothnick W, Curry T. Gonadotropin-releasing hormone agonist (GnRH-a) therapy alters activity of plasminogen activators, matrix metalloproteinases, and their inhibitors in rat models for adhesion formation and endometriosis: potential GnRH-aregulated mechanisms reducing adhesion formation. Fertil Steril 1998;69:916-923.
6. Wiczyk H, Grow D, Adams L, OShea D, Reece M. Pelvic adhesions contain sex steroid receptors and produce angiogenesis growth factors. Fertil Steril 1998;69:511-516.
7. Imai A, Tamaya T. GnRH receptor and apoptotic signaling. Vitam Horm 2000;59:1-33.
8. Lydia W, Cheung T, Wong A. Gonadotropin-releasing hormone: GnRH receptor signaling in extrapituitary tissues. FEBS J 2009;275:5479-5495.
9. Haslinger B, Kleemann R, Toet K, Kooistra T. Simvastatin suppresses tissue factor expression and increases fibrinolytic activity in tumor necrosis factor-alpha-activated human peritoneal mesothelial cells. Kidney Int 2003;63:2065-2074.
10. Imai A, Ohno T, Iida K, Fuseya T, Furui T, Tamaya T. Gonadotropin- releasing hormone receptor in gynecologic tumors: frequent expression in adenocarcinoma histologic types. Cancer 1994;74:2555-2561.
11. Imai A, Takagi H, Horibe S, Fuseya T, Tamaya T. Coupling of gonadotropin-releasing hormone receptor to Gi protein in human reproductive tract tumors. J Clin Endocrinol Metab 1996;81:3249-3253.
12. Winkler U, Bühler K, Koslowski S, Oberhoff C, Schindler A. Plasmatic haemostasis in gonadotrophin-releasing hormone analogue therapy: effects of leuprorelin acetate depot on coagulatory and fibrinolytic activities. Clin Ther 1992; 14(Suppl A):114-120.